Patent Yard Sign in
Canadian application, no grantCanada

Process for manufacture of imidazoles

CA 2428857 A1 · Owner: Arduengo, Anthony J. Iii · Inventors: Gentry, Frederick P. Jr.; Arduengo, Anthony J. Iii; Simmons, Howard E. Iii

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Imidazoles may be manufactured by reacting a glyoxal ammonia, an aldehyde, and optionally a primary amine in the presence of a Bronsted acid whose pKa is approximately equal to the pKa of the ammonium cation of the primary amine or if the primary amine is not present to the pKa of the ammonium (NH4+) , cation. The reaction may be used to make in relatively high yields a wide variety of imidazoles using relatively inexpensive starting materials. The imidazoles are useful as chemical intermediates. Formula (V) and formula (IX).

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 16, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 16, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 16, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 16, 2000
GrantedNo grant recorded
Term endedNovember 16, 2020
Patent numberCA 2428857 A1
Classification (IPC)C07D233/54 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedNov 16, 2000Term endedNov 16, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.